Why is Trident Texofab falling/rising?

As of 10-Sep, Trident Texofab Ltd's stock price is rising, currently at Rs 263.90, reflecting an increase of 4.9 or 1.89%. The stock has recently hit a new 52-week and all-time high of Rs 263.95 and has outperformed its sector by 2.28%. Over the past two days, the stock has gained 3.09%, and its performance over the last week shows an impressive increase of 8.16%. Additionally, the company has reported positive results for the last three consecutive quarters, with net sales growing by 24.20%, which has likely contributed to the stock's upward momentum. The rising investor participation, indicated by a significant increase in delivery volume, further supports the positive sentiment around the stock.
In the broader market context, Trident Texofab's short-term performance significantly outpaces the benchmark Sensex, which has only risen by 1.06% over the past week. The stock's year-to-date return of 56.90% and remarkable one-year return of 490.38% also highlight its strong performance relative to the broader market, where the Sensex has only increased by 4.21% year-to-date. This consistent outperformance over various time frames suggests that investor confidence in Trident Texofab remains robust, contributing to its rising stock price amidst a generally stable market environment.